Q1 2022 13F Holders as of 31 Mar 2022
-
Type / Class
-
Equity / Common Stock, no par value
-
Shares outstanding
-
14,965,850
-
Total 13F shares
-
2,897,889
-
Share change
-
+51,888
-
Total reported value
-
$8,171,000
-
Price per share
-
$2.82
-
Number of holders
-
24
-
Value change
-
-$99,570
-
Number of buys
-
11
-
Number of sells
-
10
Institutional Holders of CUMBERLAND PHARMACEUTICALS INC - Common Stock, no par value (CPIX) as of Q1 2022
As of 31 Mar 2022,
CUMBERLAND PHARMACEUTICALS INC - Common Stock, no par value (CPIX) was held by
24 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
2,897,889 shares.
The largest 10 holders included
RENAISSANCE TECHNOLOGIES LLC, DIMENSIONAL FUND ADVISORS LP, VANGUARD GROUP INC, BRIDGEWAY CAPITAL MANAGEMENT, LLC, ACADIAN ASSET MANAGEMENT LLC, BERKSHIRE ASSET MANAGEMENT LLC/PA, BlackRock Inc., TWO SIGMA ADVISERS, LP, TWO SIGMA INVESTMENTS, LP, and GEODE CAPITAL MANAGEMENT, LLC.
This page lists
24
institutional shareholders reporting positions in this security
for the Q1 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.